Cell And Gene Therapy Manufacturing

  1. Scalable By Design: Streamlining Cell Culture Media Manufacturing 8/15/2024

    Learn ways to help improve quality, simplify technology transfer of proprietary media formulations, and mitigate logistical challenges associated with custom media scale-up processes.

  2. DoE Methodology For Downstream Purification Of pDNA Of IEX Resins 6/16/2025

    Learn a systematic approach using Design of Experiment to optimize plasmid DNA purification. See how anion exchange resins are evaluated to enhance dynamic binding capacity and process efficiency.

  3. Thermo Fisher Scientific Customer Experience Center Overview 5/19/2025

    Explore cutting-edge single-use technologies with hands-on training at the Customer Experience Center, which is an immersive hub for innovation, learning, and bioprocessing expertise.

  4. Singapore Single-Use Site Capacity Expansion 6/1/2022

    Thermo Fisher Scientific is expanding our single-use manufacturing network globally, an expansion site closer to Asia Pacific region

  5. Understanding AI And Machine Learning's Impact On CGT with Dr. Peter Marks and Dr. Nicole Verdun 1/30/2024

    During this segment, Dr. Peter Marks and Dr. Nicole Verdun share their take on how AI and machine learning will impact FDA regulation in 2024.

  6. Developing A 2-Step Chromatographic Process For The Purification Of AAV Vectors 6/24/2025

    POROS CaptureSelect AAVX and POROS 50 HQ were tested for capture and polishing, respectively, of AAV2, AAV9 and a novel engineered capsid to achieve vectors with high purity and significant empty: full ratio improvement.

  7. Multi-Omics And Bioinformatics In Cell Culture Media Design 6/16/2025

    Learn about the impact of a multi-omics analysis, utilizing proteomics and metabolomics, in the development and optimization of media with the goal of improving titer, and making development and manufacturing more efficient.

  8. Market Demand For AAV Vectors 11/13/2023

    Here, Dave Maheu, VP, Head of Process & Analytical Development at Candel Therapeutics and Curran Simpson, Chief Operating Officer at REGENXBIO detail the key factors driving the adeno associated virus manufacturing market.

  9. Setup Made Simple With The BioTitan Retention Device 5/27/2025

    Find out how quick and simple it is to set up an assembly secured with the Thermo Scientific BioTitan Retention Device.

  10. A Collaboration With Fresenius Kabi BioPharm 5/19/2025

    Explore how biosimilar development is advancing through collaboration, innovative cell culture strategies, and the use of advanced media to meet biomanufacturing goals.